2Pfeffer MA, Brarnwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfrnction after myocardial mrarction, Results of the Survial and Ventricular Enlargement Trial[J]. N Engl J Med, 1992, 327: 667-669.
3Wiman B, Hamsten A. Correlations between fibrinolytic function and acute myocardial infarction[J]. Am J Cardilol, 1990, 66: 54-56.
4Slomaa V, Stinson V, Kark JD, et al. Association of fibrinolytic parameters with early atherosclerosis[J]. The ARIC Study. Circulation, 1995, 91: 284-290.
5Vaughan DE, Lazos SA, Tong K. Angiotensin Ⅱ regulates the expression of plasminogen activator inhisitor-1 in cultured endothelialcells[J]. J Clin Invest, 1995, 95:995-1001.
6Brown WJ, Nadeau JH, Vaughan DE. Selective stimulation of tissue type plasmmogen activator in vivo by infusion of bradykinin [J]. Thromb Haemost, 1997, 77: 522-525.
7Somega N, Morotome Y, Kodama K, et al, Supperssive effect of captopril on platelet aggregation in essencial hypertension [J].J Carsiovasc Pharmaco, 1984, 6: 840-843.
